Neuroprotection by Histone Deacetylase-Related Protein
- 1 May 2006
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 26 (9) , 3550-64
- https://doi.org/10.1128/mcb.26.9.3550-3564.2006
Abstract
The expression of histone deacetylase-related protein (HDRP) is reduced in neurons undergoing apoptosis. Forced reduction of HDRP expression in healthy neurons by treatment with antisense oligonucleotides also induces cell death. Likewise, neurons cultured from mice lacking HDRP are more vulnerable to cell death. Adenovirally mediated expression of HDRP prevents neuronal death, showing that HDRP is a neuroprotective protein. Neuroprotection by forced expression of HDRP is not accompanied by activation of the phosphatidylinositol 3-kinase-Akt or Raf-MEK-ERK signaling pathway, and treatment with pharmacological inhibitors of these pathways fails to inhibit the neuroprotection by HDRP. Stimulation of c-Jun phosphorylation and expression, an essential feature of neuronal death, is prevented by HDRP. We found that HDRP associates with c-Jun N-terminal kinase (JNK) and inhibits its activity, thus explaining the inhibition of c-Jun phosphorylation by HDRP. HDRP also interacts with histone deacetylase 1 (HDAC1) and recruits it to the c-Jun gene promoter, resulting in an inhibition of histone H3 acetylation at the c-Jun promoter. Although HDRP lacks intrinsic deacetylase activity, treatment with pharmacological inhibitors of histone deacetylases induces apoptosis even in the presence of ectopically expressed HDRP, underscoring the importance of c-Jun promoter deacetylation by HDRP-HDAC1 in HDRP-mediated neuroprotection. Our results suggest that neuroprotection by HDRP is mediated by the inhibition of c-Jun through its interaction with JNK and HDAC1.Keywords
This publication has 48 references indexed in Scilit:
- Intracellular Trafficking of Histone Deacetylase 4 Regulates Neuronal Cell DeathJournal of Neuroscience, 2005
- Targeting the JNK Signaling Pathway for Stroke and Parkinsons Diseases TherapyCurrent Drug Targets-CNS & Neurological Disorders, 2005
- Inactivation of the Myocyte Enhancer Factor-2 Repressor Histone Deacetylase-5 by Endogenous Ca2//Calmodulin-dependent Kinase II Promotes Depolarization-mediated Cerebellar Granule Neuron SurvivalJournal of Biological Chemistry, 2003
- Regulating histone acetyltransferases and deacetylasesEMBO Reports, 2003
- The Histone Deacetylase 9 Gene Encodes Multiple Protein IsoformsJournal of Biological Chemistry, 2003
- Targeting the JNK Pathway for Therapeutic Benefit in CNS DiseaseCurrent Drug Targets-CNS & Neurological Disorders, 2002
- c-Jun and the transcriptional control of neuronal apoptosisBiochemical Pharmacology, 2000
- Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylasesProceedings of the National Academy of Sciences, 2000
- Identification of a transcriptional repressor related to the noncatalytic domain of histone deacetylases 4 and 5Proceedings of the National Academy of Sciences, 2000
- Loss of heterozygosity at 7p in Wilms’ tumour developmentBritish Journal of Cancer, 2000